Feasibility of frequent monitoring of symptoms using the PRO-CTCAE in the NRG-BR004 clinical trial
Related Posts
Suruga K, Patel V, Nagasaka T, Guo Y, Shitan H, Ng D, Cohen T, Garg T, Ahlawat P, Koren O, Patel D, Gupta A, Chakravarty[...]
Gaire BP, Koronyo Y, Vit JP, Hutton A, Subedi L, Fuchs DT, Swerdlow N, Rentsendorj A, Shahin S, Martinon D, Robinson E, Ljubimov AV, Schneider[...]
Kenfield SA, Hart NH, Courneya KS, Greenwood R, Chan JM, Sison J, Zhang L, Rudman S, Ung L, Schumann M, Van Blarigan EL, McKeown S,[...]